Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial PERFECT Using Autologous CD133+ Bone Marrow Stem Cells | Reuters
Links shared publicly online about this topic.
- 1,641total visits
Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial PERFECT Using Autologous CD133+ Bone Marrow Stem Cells | Reuters
Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial PERFECT Using Autologous CD133+ Bone Marrow Stem Cells BERGISCH GLADBACH, Germany, October 29 /PRNewswire/ -- Miltenyi Biotec announces
View full resource at reuters.com
Tags: Heart, Heart Disease, Coronary Artery Disease, Bone, Disease and Condition, Stem Cell, Clinical Trial
Most Recently Shared on October 29, 2009 at 4:15 pm By:
Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT ... - Reuters http://bit.ly/3tY53L
Advertisement
